期刊文献+

右美托咪定联合Supreme喉罩麻醉在老年乳腺癌根治术中的临床应用 被引量:1

Clinical application of dexmedetomidine combined with LMA supreme general anesthesia in elderly patients undergoing radical mastectomy
下载PDF
导出
摘要 目的探讨右美托咪定联合Supreme喉罩全身麻醉在老年乳腺癌根治术患者中的临床效果、安全性及优势。方法选择60例择期行乳腺癌根治术、ASAⅠ-Ⅱ级、年龄65-75岁的老年患者,随机分为Supreme喉罩组(S组n=30)和右美托咪定联合Supreme喉罩组(D组n=30),分别记录麻醉诱导前(T0)、诱导后(T1)、喉罩置入即刻(T2)、切皮时(T3)及喉罩拔除即刻(T4)各时点患者的平均动脉压(MAP)、心率(HR);计算患者全身麻醉药物总用量、苏醒及拔除喉罩时间;观察术中返流误吸,苏醒期躁动、呛咳、寒战情况及术后声嘶、咽痛等不良反应发生率;评价术后1、2、6 h的视觉模拟评分(VAS)。结果与麻醉诱导前基础值(T0)相比,S组MAP、HR在T1时点显著降低(P〈0.05),T3时点显著增高(P〈0.05),T2、T4时点略增高但差异无统计学意义(P〉0.05);D组MAP在T1、T2、T3、T4时点变化不显著,HR在T1、T2、T3时点显著下降(P〈0.05)。与D组相比,S组MAP在T1时点显著降低(P〈0.05),在T3时点显著增高(P〈0.05),在T2、T4时点略增高,但差异无统计学意义(P〉0.05),HR在T2、T3时点显著增高(P〈0.05),HR在T1、T4时点变化不显著(P〉0.05)。与S组相比,D组全身麻醉药用量明显减少(P〈0.05),苏醒时间和拔除喉罩时间明显缩短(P〈0.05),苏醒期躁动、呛咳、寒战、术后咽痛发生率明显降低(P〈0.05)。两组患者均无术中返流误吸及术后声嘶发生。D组术后1 h、2 h VAS评分明显小于S组(P〈0.05),术后6 h无明显差异(P〉0.05)。结论右美托咪定联合Supreme喉罩用于老年乳腺癌根治术全身麻醉,具备血流动力学平稳,全身麻醉药用量少,苏醒和拔除喉罩时间短及术后不良反应少、舒适度高的优势。 Objective To evaluate the clinical efficacy and safety of dexmedetomidine combined with LMA Supreme general anesthesia in elderly patients undergoing radical mastectomy.Methods Sixty patients aged 65-75 years,ASA grade Ⅰ-Ⅱ undergoing elective radical mastectomy were randomly allocated in LMA Supreme group(Group S) and dexmedetomidine combined with LMA Supreme(Group D) with 30 cases each.The SBP,DBP,HR were recorded before anesthesia induction(T0),after induction(T1) immediately after inserting LMA(T2),on skin incision(T3),immediately after removing LMA(T4).The dosage of general anesthetics,the time of revival and extubation were calculated.Intraoperative regurgitation and pulmonary microaspiration,agitation bucking and ague at awakening,postoperative hoarseness and pharyngodynia were documented.VAS was evaluated after1,2 and 6 hours of operation.Results Compared with the baseline value at T0,the SBP,DBP,HR in group S were significantly decreased at T1(P〈0. 05) and significantly increased at T3(P〈0. 05).The HR was significantly decreased at T1,T2,T3 in group D(P〈0. 05).Compared with group D,the SBP and DBP in group S were significantly lower at T1(P〈0. 05);and the SBP,DBP,HR were higher at T3(P〈0. 05).No intraoperative regurgitation and pulmonary microaspiration and postoperative hoarseness were found in both groups.Compared with group S,the dosage of general anesthetics and the time of revival and extubation in group D were significantly shortened and the agitation bucking ague at awakening and postoperative pharyngodynia were significantly decreased(P〈0. 05).The VAS in group D at 1,2 hours after operation was lower than that in group S(P〈0. 05).Conclusion Dexmedetomidine combined with LMA Supreme general anesthesia has a satisfactory and safe effect with better hemodynamic stability,less consumption of anesthetics and faster consciousness recovery in elderly patients undergoing radical mastectomy.
出处 《同济大学学报(医学版)》 CAS 2014年第6期94-97,133,共5页 Journal of Tongji University(Medical Science)
关键词 右美托咪定 SUPREME喉罩 老年患者 乳腺肿瘤根治术 dexmedetomidine LMA supreme elderly patients radical mastectomy
  • 相关文献

参考文献11

  • 1Eschertzhuber S, Brimacombe J, Hohlrieder M, et al. The LMA supreme-a single use laryngeal mask airway with an oesophageal vent. A randomised, cross-over study with the laryngeal mask airway ProSeal in paralysed, anesthetised patients[J]. Anesthesia, 2009, 64(1) 79 -83.
  • 2Cormack JR, Orme RM, Costello TG. The role of alpha2-agonists in neurosurgery [J]. J Clin Neurosci, 2005,12(4) : 375 -378.
  • 3Timmermann A, Cremer S, Heuer J, et al. Laryngeal mask LMA Supreme. Application by medical personnel inexperienced in airway management [ J ]. Anesthesist, 2008,57 : 970 - 975.
  • 4Timmermann A, Cremer S, Eich C, et al. Prospective clinical and fiberoptic evaluation of the supreme laryngeal mask airway [J]. Anesthesiology, 2009,110 (2) : 262 - 265.
  • 5Yildiz M, Tavlan A, Tuncer S, et al. Effect of dexmedetomidine on haemodynamic responses to laryn- goscopy and intubation: perioperative haemodynamics and anesthetic requirements [ J ]. Drugs R D, 2006,7 (1) : 43 -52.
  • 6Kunisawa T, Nagata O, Nagashima M, et al. Dexmedetomidine suppresses the decrease in bloodpressure during anestheticinduction and blunts the cardiovascular response to tracheal intubation [J]. J Clin Anesth, 2009,21 ( 3 ) : 194 - 199.
  • 7刘海健,翁浩,王建光.右美托咪定对扁桃体摘除术麻醉苏醒期躁动的影响[J].临床麻醉学杂志,2012,28(8):772-774. 被引量:37
  • 8曾静贤,钟娃.NI指数与右美托咪定镇静深度相关性研究[J].岭南急诊医学杂志,2011,16(2):123-124. 被引量:21
  • 9Sessler DI, Thermoregulatory defense mechanicsms [J]. Crit Care Med, 2009,37(7) : $203 -210.
  • 10张燕,郑利民.右美托咪啶的药理作用及临床应用进展[J].国际麻醉学与复苏杂志,2007,28(6):544-547. 被引量:224

二级参考文献34

  • 1Kreuer S,Bruhn J,Stracke C,et al.Narcotrend or bispectral index monitoring during desflurane-remifentanil anesthesia:a comparison w ith a standard practice protocol.A nesthAn alg,2005,101(2):427.
  • 2Shmidt GN,Bischoff P,Standl T,et al.Comparative evaluation of Narcotrend,Bispectral index,and classical electroencephalographic variable during induction,maintenance and emergence of propofol-fem ifentanil anesthsia.Anesth Analg,2004,98(5):1346.
  • 3Grouven U,Beger F,Schultz B,et al.Correlation of narcotrend index,entropy measures,and spectral parameters with calculated propofol-remifentanil anaesthesia.J Clin Monit comput,2005,18:231.
  • 4Kreuer S,Molter G,Biedler A,et al.Narcotrend stages and end-tidal desflurane concentrations.An investigation durng recovery from desflurane/remifentanil anaesthesia.(in German) Anaesthesia,2003,51:800.
  • 5Sturaitis MK, Braverman B, Tuman KJ. Effect of dexmedetomidine on somatosensory evoked potentials in patients during craniotomy. Anesthesiology, 2003 (abstr) , 99 :A291.
  • 6Paris A, Mantz J, Tonner PH, et al. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the [ alpha]2A - adrenoceptor subtype. Anesthesia & Analgesia, 2006, 102:456-461.
  • 7Dahmani S, Rouelle D, Gressens P, et al. Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions. Anesthesiology, 2005, 103:969- 977.
  • 8Taniguehi T, Kidani Y, Kanakura H, et al. Effects of dexmedetomidine on mortality rate and inflammatory, responses to endotoxin - induced shock in rats. Critical Care Medicine, 2004, 32:1322-1326.
  • 9Davies MF, Haimor F, Lighthall G, et al. Dexmedetomidine fails to cause hyperalgesia after cessation of chronic administration. Anesthesia & Analgesia, 2003, 96 : 195-200.
  • 10El - Kerdawy H, Gouda N, Kamal H. Dexmedetomidine as anaesthetic adjunct for patients undergoing off - pump coronary artery bypass grafting. Egyptian Journal of Anaesthesia, 2004, 20:29-34.

共引文献279

同被引文献16

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部